Search by Drug Name or NDC

NDC 59212-0002-01 Dyrenium 50 mg/1 Details

Dyrenium 50 mg/1

Dyrenium is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Concordia Pharmaceuticals Inc.. The primary component is TRIAMTERENE.

MedlinePlus Drug Summary

Triamterene is used alone or with other medications to treat edema (fluid retention; excess fluid held in body tissues) caused by various conditions, including liver and heart disease. Triamterene is in a class of medications called diuretics ('water pills'). It causes the kidneys to eliminate unneeded water and sodium from the body into the urine, but reduces the loss of potassium.

Related Packages: 59212-0002-01
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Triamterene

Product Information

NDC	59212-0002
Product ID	59212-002_ca00e551-999b-48d9-9306-095c961c06e3
Associated GPIs	37500030000105
GCN Sequence Number	008226
GCN Sequence Number Description	triamterene CAPSULE 50 MG ORAL
HIC3	R1H
HIC3 Description	POTASSIUM SPARING DIURETICS
GCN	35041
HICL Sequence Number	003666
HICL Sequence Number Description	TRIAMTERENE
Brand/Generic	Brand
Proprietary Name	Dyrenium
Proprietary Name Suffix	n/a
Non-Proprietary Name	Triamterene
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	CAPSULE
Route	ORAL
Active Ingredient Strength	50
Active Ingredient Units	mg/1
Substance Name	TRIAMTERENE
Labeler Name	Concordia Pharmaceuticals Inc.
Pharmaceutical Class	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC]
DEA Schedule	n/a
Marketing Category	NDA
Application Number	NDA013174
Listing Certified Through	2024-12-31

Package

NDC 59212-0002-01 (59212000201)

Pricing Information	N/A
NDC Package Code	59212-002-01
Billing NDC	59212000201
Package	100 CAPSULE in 1 BOTTLE (59212-002-01)
Marketing Start Date	1999-10-01
NDC Exclude Flag	N